Technical Data
B0085-04
BRCAA1
Description:
The novel BRCAA1 protein’s epitope, SSKKQKRSHK, was mapped to the cytoplasm of MCF7 cells. Immunohistochemistry analysis has shown that the antigen epitope exhibits positive expression in 65% of breast cancer specimens. Its expression is associated with characteristics that are associated with prognosis of breast cancer, and its sera antibody level may be helpful for breast cancer diagnosis.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 1:500-1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ug-20°CBlue IceHumanRabbit
Concentration:
~1mg/ml
Immunogen:
BRCAA1 peptide, SSKKQKRSHK
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a liquid in PBS, 0.02% sodium azide.
Specificity:
Reacts with residues 1046-1055 [SSKKQKRSHK] of the 136kD human, mouse and rat BRCAA1 protein.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1.Cui, D. et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1136-45.